Secure a free, customized workshop now. Online or in your pharmacy.
No postage costs for you. Our delivery is free of charge, with no minimum order value.
You can return all unopened products easily and free of charge. We will refund the full amount.
We're offering you and your team free medical education and free consultation
The well-being of patients is our highest priority. We aim to facilitate the development of a regulated cannabis market in Europe to help patients obtain the best possible therapy.
Safety and quality are the most important factors for us. Our cannabis is imported from GMP-certified producers, who adhere to the highest standards. Every step of our supply chain from the cultivation to the distribution is regulated and controlled.
Although the beneficial medical properties of cannabis are increasingly established, developments aimed at leveraging these benefits have been slow in Europe. Cannovum clearly focuses on the European market, pioneering our cannabis revolution.
Pharmacists can easily register with our online shop to place orders. If you have any questions about our products and the associated service, please contact our trained service staff.
Following the coalition agreement, Cannovum AG will enter into the recreational cannabis market. The present offer in the field of medical cannabis will be maintained and further expanded.
This is an extension of the wholesale permit and allows the trade of active ingredients. One of the main active ingredients of cannabis is THC, which is considered to have the greatest pharmaceutical potential and therapeutic efficacy.
Priv. Doz. Dr. med. habil. Philipp Sewerin is the new member of the supervisory board as well as the Medical Advisory Board. Dr. Sewerin is a specialist in internal medicine and rheumatology at the university clinic in Düsseldorf.
If you would like to invest in Cannovum feel free to check and contact us in our investor relations page.
Get the latest information and insights:
© 2021 Cannovum AG. All rights reserved.
